AstraZeneca has announced a fresh investment of ₹166 crore into its Global Capability Center (GCC) in Bengaluru, India. The expansion will see the addition of 400 new roles, further deepening the center’s capabilities in IT, data analytics, cybersecurity, and digital health.
The investment is part of the pharmaceutical major’s strategic commitment to India as a key global innovation and tech hub. AstraZeneca’s Bengaluru GCC currently houses close to 1400 professionals and plays a pivotal role in its digital-first R&D and commercial transformation journeys.
